That is pure speculation on your part, and is really not even rational as stability is chemical specific and in the case of embeda, it is morphine,not oxycodone. Why would the largest pharma in the world proceed with very expensive phase 3 if they had stability issues? It makes no sense, and if they did the FDA would be very unhappy with them conducting human clinical trials with and unstable product.
News 
Market Data 
Discover 
